secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001558370-22-016619
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q3 revenue up 24% to $65.3M; raises FY2022 guidance
-------------------------------------------------------------------

- Q3 revenue $65.3M (+24% YoY); net loss $2.3M ($0.11/sh) vs loss $3.4M ($0.17) a year ago.
- Non-GAAP net income $1.9M vs non-GAAP loss $1.6M; Adjusted EBITDA $7.2M vs $4.1M.
- Airway clearance revenue $11.0M (incl. AffloVest); lymphedema revenue up 5%.
- Raises FY2022 revenue guidance to $242-245M (16-18% growth) from prior $238-242M.
- Gross margin improved to 71.7% from 70.4%; cash $23.4M, debt $49.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022016619/0001558370-22-016619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022016619/tcmd-20221107x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-016619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer